Search Local Studies

On this page you can search through all local studies (clinical trials) being conducted at the Indiana University - Purdue University Indianapolis. Please enter your search term(s) in the search box below, choose the appropriate checkbox and sorting options, and click the Search button.

If you are unable to locate a study for a specific disease/condition (or studies for healthy volunteers), please contact the CTSI at: (317) 278-2176.



Sign up here to receive information about research studies in Indiana!



IndianaCTSI Clinical Trials Search results for: 'prostate cancer'

Search Results:

Click on study title for more information about that study.

Bladder, Kidney, Prostate & Urinary Conditions (3)


1204008432 - A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to compare two methods of delivering high dose radiation to the prostate to see if the effects of the treatments are similar. 05-17-2012 No
1108006598 - Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to compare the effects of dose-escalated radiation therapy with or without hormone therapy on prostate cancer. 01-25-2012 No
1011003612 - A multicenter clinical study of the Sonablate? 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU (STAR Trial) Age Range: 40 Years - 85 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to test a new treatment process for prostate cancer. 09-16-2011 No

Cancer (18)


See all studies related to 'prostate cancer' within Cancer

1410410979 (16544) - A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostatic Neoplasms The purpose of this study is to evaluate bone scan response at Week 24 based on the quantified technetium-99 bone scan lesion area (BSLA). 02-02-2015 No
1406343551 (3104007) - Efficacy and Safety Study of ODM-201 in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to assess the safety and efficacy of ODM-201 in patients with non-metastatic castration-resistant prostate cancer. 01-07-2015 No
1010002081 (1403447865) - Radiation Therapy in Treating Patients With Stage II Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer This randomized phase III trial is studying several different radiation therapy regimens to compare how well they work in treating patients with stage II prostate cancer. 11-04-2014 No
S1216 - S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700 versus ADT + bicalutamide. 08-27-2014 No
RTOG0534 - A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer This randomized phase III trial is studying prostate radiation therapy to see how well it works compared with short-term androgen deprivation therapy given together with pelvic lymph node radiation therapy with or without prostate radiation therapy in treating patients with a rising PSA after surgery for prostate cancer. 05-12-2014 No

Men's Health (10)


See all studies related to 'prostate cancer' within Men's Health

1406343551 (3104007) - Efficacy and Safety Study of ODM-201 in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to assess the safety and efficacy of ODM-201 in patients with non-metastatic castration-resistant prostate cancer. 01-07-2015 No
1010002081 (1403447865) - Radiation Therapy in Treating Patients With Stage II Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer This randomized phase III trial is studying several different radiation therapy regimens to compare how well they work in treating patients with stage II prostate cancer. 11-04-2014 No
1212010175 - Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer This randomized phase II trial studies abiraterone acetate and prednisone together with veliparib to see how well it works compared to abiraterone acetate and prednisone alone in treating patients with metastatic hormone-resistant prostate cancer. 03-20-2014 No
1306011624 - Phase II Trial to Evaluate Benefit of Early Switch from first-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the opposite sequence, exploring molecular markers and mechanisms of taxane resistance in men with Metastatic Castration-Resistant Prost Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to evaluate the benefit of an early switch from docetaxel 75mg/m2 plus prednisone to cabazitaxel 25mg/m2 plus prednisone. 08-02-2013 No
1302010681 - The Pacific Clinical Trial: A Randomized Phase II Study Evaluating OGX-427 in Patients With Metastatic Castrate-Resistant Prostate Cancer (MCRPC)Who Have Prostate-Specific Antigen (PSA) Progression While Receiving Abiraterone: Hoosier Oncology Group GU12 Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to evaluate the anti-tumor effects of adding OGX-427 to continuing abiraterone acetate and prednisone treatment in men with metastatic castrate-resistant prostate cancer (MCRPC) who have prostate-specific antigen (PSA) progression. 04-02-2013 No

Nutrition (1)


CTSU/CALBG 70807 - The Men's Age Range: 50 Years - 80 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to test whether or not telephone-based counseling changes the eating habits of men with prostate cancer. 08-13-2012 No